These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21327127)

  • 1. In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.
    Spratt JM; Britton WJ; Triccas JA
    Bioeng Bugs; 2010; 1(1):61-5. PubMed ID: 21327127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
    Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
    Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted induction of antigen expression within dendritic cells modulates antigen-specific immunity afforded by recombinant BCG.
    Kong CU; Ng LG; Nambiar JK; Spratt JM; Weninger W; Triccas JA
    Vaccine; 2011 Feb; 29(7):1374-81. PubMed ID: 21211591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH; He HY; Zhang BS
    J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.
    Wang J; Qie Y; Liu W; Wang H
    Hum Vaccin Immunother; 2012 Dec; 8(12):1869-74. PubMed ID: 22906934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.
    Sali M; Di Sante G; Cascioferro A; Zumbo A; Nicolò C; Donà V; Rocca S; Procoli A; Morandi M; Ria F; Palù G; Fadda G; Manganelli R; Delogu G
    Infect Immun; 2010 Dec; 78(12):5202-13. PubMed ID: 20921146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination.
    Geluk A; Lin MY; van Meijgaarden KE; Leyten EM; Franken KL; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jun; 75(6):2914-21. PubMed ID: 17387166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HspX vaccination and role in virulence in the guinea pig model of tuberculosis.
    Wieczorek AE; Troudt JL; Knabenbauer P; Taylor J; Pavlicek RL; Karls R; Hess A; Davidson RM; Strong M; Bielefeldt-Ohmann H; Izzo AA; Dobos KM
    Pathog Dis; 2014 Aug; 71(3):315-25. PubMed ID: 24616427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.
    Horwitz MA; Harth G
    Infect Immun; 2003 Apr; 71(4):1672-9. PubMed ID: 12654780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
    Dai FY; Wang JF; Gong XL; Bao L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule.
    Taylor JL; Wieczorek A; Keyser AR; Grover A; Flinkstrom R; Karls RK; Bielefeldt-Ohmann H; Dobos KM; Izzo AA
    Immunol Cell Biol; 2012 Nov; 90(10):945-54. PubMed ID: 22801575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
    Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
    Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.
    Festjens N; Bogaert P; Batni A; Houthuys E; Plets E; Vanderschaeghe D; Laukens B; Asselbergh B; Parthoens E; De Rycke R; Willart MA; Jacques P; Elewaut D; Brouckaert P; Lambrecht BN; Huygen K; Callewaert N
    EMBO Mol Med; 2011 Apr; 3(4):222-34. PubMed ID: 21328541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
    Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
    J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.